Clinical Trial Update: Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 safety and tolerability trial of MBX-2044 in patients with Type 2 Diabetes Mellitus has completed, reporting safety and tolerability outcomes. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MBX-2044

Snippet

Sponsor: Gilead Sciences | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED